Results 131 to 140 of about 29,316 (170)

儿童肝肿瘤国际协作组和中国儿童肿瘤组新危险度分层在肝母细胞瘤预后评估中的应用比较

Zhongshan Daxue xuebao. Yixue kexue ban
目的比较儿童肝肿瘤国际协作组（CHIC）和新中国抗癌协会小儿肿瘤专业委员会（CCCG）肝母细胞瘤（HB）危险度分层对中国HB患儿的预后预测效应和化疗指导价值，以期确定适合中国HB患儿的危险度分层。方法本研究回顾性分析2010年2月至2023年9月于中山大学附属第一医院初次诊断年龄＜18岁的403例HB患儿的临床资料，比较CHIC和新CCCG危险度分层的预后预测效应和化疗指导价值。使用SPSS 27.0进行统计分析。结果①按照新CCCG危险度分层，并且采用和未采用CCCG-HB ...
李珍, 蒋宏, 王文青, 王瑗琪, 黄礼彬, 刘钧澄, 薛红漫   +6 more
doaj  

[Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy 
Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Hu Y, Zhao J, Gao X, Xu Y, Wang M.
europepmc   +1 more source

[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients
with Stage IB-IIIB Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Li Z, Wang X, Wang Y, Cui Z, Wang X, Li X, Jiang G, Wang X.   +7 more
europepmc   +1 more source

[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Y, Song X, Sun R, Dong X, Liu H.
europepmc   +1 more source

[Circ_EPHB4 regulates temozolomide sensitivity in glioma cells through the miR-424-5p/Wnt3 axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liao Y, Liu J, Liu B, Fei X, Jin C.
europepmc   +1 more source

[Formulation of the Best Practice Evidence-Based Nutrition Management Protocol for Nasopharyngeal Carcinoma Patients Undergoing Chemoradiotherapy]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Cheng Y, Liu H, Ma Y, Yang T, Hu W.
europepmc   +1 more source

Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer [PDF]

, 2009
Jiandong ZHANG, Jinming YU, Xinshuang YU
core  

[Clinical characteristics and prognosis of chronic disseminated candidiasis in children with acute leukemia following chemotherapy: a multicenter clinical study]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Jiang XH, Liu PJ, Wu CP, Weng KZ, Zhuang SQ, Huang SX, Wang XF, Zheng YZ.   +7 more
europepmc   +1 more source

[Rituximab combined with intensive immunochemotherapy for sporadic adult Burkitt lymphoma: efficacy and prognosis analyse]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Dong CM, Zou HS, Zhang W, Liu W, Wang Y, Liu HM, Xie T, Li H, Wang Q, Huang WY, Yi SH, An G, Qiu LG, Zou DH.   +13 more
europepmc   +1 more source

[Efficacy and safety of transcatheter arterial chemoembolization followed by hepatic arterial infusion chemotherapy combined with TKI and PD-1 inhibitors as first-line treatment for advanced hepatocellular carcinoma]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhang L, Liu X, Hu X, Wang J, Yu X, Li G, You H, Zhang Q, Zhang H.   +8 more
europepmc   +1 more source